guanfacine has been researched along with Chronic Disease in 3 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of guanfacine, a centrally acting antihypertensive, on blood pressure, heart rate, plasma renin activity, serum aldosterone, plasma norepinephrine, and renal function were evaluated in 16 patients with hypertension with biopsy-proved chronic glomerulonephritis." | 7.67 | Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis. ( Gomi, T; Ikeda, T; Nakayama, D; Sakurai, J; Yuhara, M, 1988) |
| "Effects of guanfacine, a centrally acting antihypertensive, on blood pressure, heart rate, plasma renin activity, serum aldosterone, plasma norepinephrine, and renal function were evaluated in 16 patients with hypertension with biopsy-proved chronic glomerulonephritis." | 3.67 | Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis. ( Gomi, T; Ikeda, T; Nakayama, D; Sakurai, J; Yuhara, M, 1988) |
| "Guanfacine was associated with a number of side effects." | 2.72 | No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. ( Henn-Haase, C; Hierholzer, RW; Lenoci, M; Lindley, SE; Marmar, CR; Metzler, TJ; Neylan, TC; Otte, C; Samuelson, KW; Schoenfeld, FB; Yesavage, JA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neylan, TC | 1 |
| Lenoci, M | 1 |
| Samuelson, KW | 1 |
| Metzler, TJ | 1 |
| Henn-Haase, C | 1 |
| Hierholzer, RW | 1 |
| Lindley, SE | 1 |
| Otte, C | 1 |
| Schoenfeld, FB | 1 |
| Yesavage, JA | 1 |
| Marmar, CR | 1 |
| Erina, EV | 1 |
| Beliakova, EV | 1 |
| Charyev, KhE | 1 |
| Ikeda, T | 1 |
| Gomi, T | 1 |
| Yuhara, M | 1 |
| Sakurai, J | 1 |
| Nakayama, D | 1 |
2 trials available for guanfacine and Chronic Disease
| Article | Year |
|---|---|
No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.
Topics: Adrenergic alpha-Agonists; Chronic Disease; Comorbidity; Double-Blind Method; Guanfacine; Humans; Mo | 2006 |
[Estulic (guanfacine) in the treatment of arterial hypertension].
Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Guanfacine; Heart; Hemodynam | 1992 |
1 other study available for guanfacine and Chronic Disease
| Article | Year |
|---|---|
Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Catecholamines; Chronic Disease; Drug A | 1988 |